questionText: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 31 October 2024 to Question 11248 on Coronavirus: Vaccination, what discussions the MHRA has had with industry safety regulators on the potential implications of the Pfize
answerText: The study abstract has been reviewed by the Medicines and Healthcare products Regulatory Agency (MHRA), as part of its continuous post approval safety monitoring procedures for the Pfizer-BioNTech COVID-19 Vaccine (Comirnaty). The abstract is available at...
heading: Coronavirus: Vaccination